Responses
Poster Presentations
SLE, Sjögren's and APS - treatment
SAT0258 Synergetic b-cell immunomodulation with rituximab and belimumab is clinically effective in severe and refractory systemic lupus erythematosus – the synbiose proof-of-concept study
Compose a Response to This Article
Other responses
No responses have been published for this article.